Working Toward Animal-Free Processing: One Vendor Company's Approach to Facility Operation

摘要

Biological therapeutics is one of the fastest growing segments of the pharmaceutical industry so much in fact that the overall cell culture media and supplements market used in bioprocessing applications is reportedly near 800 dollar million (l). An increasingly important trend in cell culture is risk reduction throughout the supply chain, including a stringent focus on key raw materials. Accordingly, the industry has increasingly adopted animal-component-free materials to mitigate concerns over safety, transmissible spongiform encephalopathies, and other contaminations.